Floatz logo

Inno-206

Cyclophosphamide

Second Affiliated Hospital of Soochow UniversityPhase 3Dormant
BB
67/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
53/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Cyclophosphamide cohort.

Asset / SponsorPhaseRating
FILGRASTIM
Second Affiliated Hospital of Soochow University
Phase 3BB
Cyclophosphamide
Second Affiliated Hospital of Soochow University
Phase 3BB
TAMOXIFEN
National Cancer Institute (NCI)
Phase 3BB
Ciprofloxacin
National Cancer Institute (NCI)
Phase 3B
PREDNISONE TABLETS
Second Affiliated Hospital of Soochow University
Phase 2CCC

View all 11 →

Same molecule, other indications

Inno-206 is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
77 / 100
View asset →
plasma cell myelomaDormant
BBB
Indicative ·
77 / 100
View asset →
Recurrent Adult Acute Lymphoblastic LeukemiaDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →